Search research articles
Contact Us
Filters
Showing results (261-270 of 351) with videos related to
Page
of 36
Sort By:
Journal of Nanoscience and Nanotechnology
|
May 10, 2008
First-principles study of silicon nanocrystals: structural and electronic properties, absorption, emission, and doping
Stefano Ossicini, O Bisi, Elena Degoli, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 13, 2020
Refractory and 17p-deleted chronic lymphocytic leukemia: improving survival with pathway inhibitors and allogeneic stem cell transplantation
L Farina, F Barretta, L Scarfò, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 20, 2008
Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysis
Johannes Schetelig, Anja van Biezen, Ronald Brand, et al.
EJVES Vascular Forum
|
October 10, 2024
Outcomes Following Vascular and Endovascular Procedures Performed During the First COVID-19 Pandemic Wave
Panagiota Birmpili, Ruth A Benson, Brenig Gwilym, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 18, 2005
Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide
Claudio Praga, Jonas Bergh, Judith Bliss, et al.
Plos One
|
October 12, 2013
Comparison of allogeneic stem cell transplantation and non-transplant approaches in elderly patients with advanced myelodysplastic syndrome: optimal statistical approaches and a critical appraisal of clinical results using non-randomized data
Ronald Brand, Hein Putter, Anja van Biezen, et al.
Leukemia
|
June 14, 2017
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia
V Santini, B Allione, G Zini, et al.
The Lancet. Oncology
|
October 30, 2025
Measurable residual disease-guided interventions in patients with acute myeloid leukaemia undergoing allogeneic haematopoietic cell transplantation: best practice recommendations from the European Society for Blood and Marrow Transplantation Practice Harmonisation and Guidelines Committee
Jaime Sanz, Gesine Bug, Fabio Ciceri, et al.
Blood
|
May 24, 2008
WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
Emilio Paolo Alessandrino, Matteo Giovanni Della Porta, Andrea Bacigalupo, et al.
Blood
|
October 25, 2013
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD
Attilio Olivieri, Michele Cimminiello, Paolo Corradini, et al.
Page
of 36
Search research articles
Search
Showing results (261-270 of 351) with videos related to
Sort By:
Page
of 36
Journal of Nanoscience and Nanotechnology
|
May 10, 2008
First-principles study of silicon nanocrystals: structural and electronic properties, absorption, emission, and doping
Stefano Ossicini, O Bisi, Elena Degoli, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 13, 2020
Refractory and 17p-deleted chronic lymphocytic leukemia: improving survival with pathway inhibitors and allogeneic stem cell transplantation
L Farina, F Barretta, L Scarfò, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 20, 2008
Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysis
Johannes Schetelig, Anja van Biezen, Ronald Brand, et al.
EJVES Vascular Forum
|
October 10, 2024
Outcomes Following Vascular and Endovascular Procedures Performed During the First COVID-19 Pandemic Wave
Panagiota Birmpili, Ruth A Benson, Brenig Gwilym, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 18, 2005
Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide
Claudio Praga, Jonas Bergh, Judith Bliss, et al.
Plos One
|
October 12, 2013
Comparison of allogeneic stem cell transplantation and non-transplant approaches in elderly patients with advanced myelodysplastic syndrome: optimal statistical approaches and a critical appraisal of clinical results using non-randomized data
Ronald Brand, Hein Putter, Anja van Biezen, et al.
Leukemia
|
June 14, 2017
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia
V Santini, B Allione, G Zini, et al.
The Lancet. Oncology
|
October 30, 2025
Measurable residual disease-guided interventions in patients with acute myeloid leukaemia undergoing allogeneic haematopoietic cell transplantation: best practice recommendations from the European Society for Blood and Marrow Transplantation Practice Harmonisation and Guidelines Committee
Jaime Sanz, Gesine Bug, Fabio Ciceri, et al.
Blood
|
May 24, 2008
WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
Emilio Paolo Alessandrino, Matteo Giovanni Della Porta, Andrea Bacigalupo, et al.
Blood
|
October 25, 2013
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD
Attilio Olivieri, Michele Cimminiello, Paolo Corradini, et al.
Page
of 36